Retraction notice to “Safety and Efficacy Of Sorafenib In Patients With Castrate Resistant Prostate Cancer: A Phase II Study” [Urologic Oncology: Seminars and Original Investigations 28 (2010) 21–27]

Urologic Oncology: Seminars and Original Investigations · Elsevier

Аннотация

Publication date: Available online 7 November 2026 Source: Urologic Oncology: Seminars and Original Investigations Author(s): Mohammad Reza Safarinejad

Читать у издателя →

Похожие статьи